Julie Snyder, host of Noovo’s La Semaine des 4 Julie, is on a mission: to save the lives of women like her own mother, who died of ovarian cancer in 2018. And to make ovarian and endometrial cancers detectable and curable. The stats paint a grim picture: when diagnosed late, only 10-30% of women with ovarian or endometrial cancer survive. Combined, these cancers are the fourth leading cause of death for Canadian women. You can make the difference between life and death.
Join Julie by supporting the McGill University Health Centre team working to save lives.
Together, we can stop this silent killer from claiming additional lives and transform the future of women's health.
Highest combined cancer killer of Canadian women
Canadian women were diagnosed with ovarian cancer in 2020
Of women with ovarian cancer are diagnosed in the late stages
Ovarian and endometrial cancers are silent killers, seldom presenting symptoms until it is too late. The sooner these cancers are detected, the more likely they are to be survivable. Gynecologic oncologist Dr. Lucy Gilbert has the answer: the DOvEEgene test. As routine as a pap smear, this minimally invasive test can detect cancer using DNA analysis before it becomes a death sentence. Dr. Gilbert and her team have just begun the final clinical trial of this lifesaving test, and she needs your help to make it a standard of women’s care. It's a historic discovery, made in Quebec! Help Julie and Dr. Gilbert ensure there are no more women lost.
The DOvEE team is revolutionizing the way we treat ovarian and endometrial cancers. The MUHC Foundation is helping make that dream possible.Learn More